Nasdaq

Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This ...
Nasdaq

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

SUNNYVALE, Calif., March 11, 2024 /PRNewswire/ -- Cepheid announced today that it has received clearance from the U.S. Food and Drug Administration for Xpert® Xpress GBS, a dual-target molecular ...
Seeking Alpha

Danaher's Cepheid gets expanded FDA clearance for Xpert Xpress MVP

Danaher (NYSE:DHR) unit Cepheid said it has been given expanded FDA clearance with CLIA waiver for its Xpert Xpress MVP for the detection of bacterial vaginosis, vulvovaginal candidiasis and ...
Seeking Alpha

Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

Multiplex Vaginal Panel (MVP) delivers faster identification of three distinct conditions within an hour SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received ...